Ras endoprotease inhibitors are potent cytotoxic agents against acute lymphoblastic leukemia.

被引：0
|
作者：
Perrey, DA
Scannell, MP
Narla, RK
Navara, C
Uckun, FM
机构：
[1] Parker Hughes Canc Ctr, St Paul, MN USA
[2] Hughes Inst, St Paul, MN USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2470
引用
收藏
页码：599A / 599A
页数：1
相关论文
共 50 条
  • [1] Ras endoprotease inhibitors are potent antileukemic agents.
    Perrey, DA
    Narla, RK
    Navara, CS
    Uckun, FM
    CLINICAL CANCER RESEARCH, 1999, 5 : 3789S - 3789S
  • [2] Cysteine chloromethyl ketone derivatives are potent cytotoxic agents against acute lymphoblastic leukemia and multiple myeloma cells.
    Perrey, DA
    Narla, RK
    Navara, CS
    Uckun, FM
    BLOOD, 1999, 94 (10) : 195B - 195B
  • [3] Chloromethyl ketone derivatives as Ras endoprotease inhibitors are potent anti-cancer agents.
    Perrey, DA
    Narla, RK
    Navara, CS
    Uckun, FM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1198 - U1198
  • [4] Genetic Polymorphisms and the toxicity of antileukemic agents in children with acute lymphoblastic leukemia.
    Kishi, S
    Cheng, C
    Pei, DQ
    Das, S
    Cook, EH
    Hijiya, N
    Rizzari, C
    Rosner, G
    Pui, CH
    Evans, WE
    Relling, MV
    BLOOD, 2004, 104 (11) : 542A - 542A
  • [5] Rearranged Infant Acute Lymphoblastic Leukemia.
    Stam, Ronald W.
    Den Boer, Monique L.
    Schneider, Pauline
    de Boer, Jasper
    Hagelstein, Jill
    Sallan, Stephen E.
    Brady, Hugh J. M.
    Armstrong, Scott
    Pieters, Rob
    BLOOD, 2008, 112 (11) : 668 - 668
  • [6] Acute lymphoblastic leukemia at relapse in an adult with acute myeloid leukemia.
    Lounici, A
    ConyMakhoul, P
    Lacombe, F
    Boiron, JM
    Merlio, JP
    Marit, G
    Reiffers, J
    BLOOD, 1996, 88 (10) : 3391 - 3391
  • [7] Cytotoxic T cell response against the chimeric TEL-AML1 protein in childhood Acute Lymphoblastic Leukemia.
    Yotnda, P
    Garcia, F
    Even, J
    Kourilsky, P
    Lemonnier, F
    LangladeDemoyen, P
    Vilmer, E
    BLOOD, 1996, 88 (10) : 837 - 837
  • [8] The efficacy of tyrosine kinase inhibitors with steroid in phi- acute lymphoblastic leukemia.
    Gurman, Gunhan
    Merter, Mustafa
    Atilla, Erden
    Sahin, Ugur
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Ilhan, Osman
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] RAS AND FMS MUTATIONS FOLLOWING CYTOTOXIC THERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    TAYLOR, C
    MCGLYNN, H
    CARTER, G
    BAKER, AH
    WARREN, N
    RIDGE, SA
    OWEN, G
    THOMPSON, E
    THOMPSON, PW
    JACOBS, A
    PADUA, RA
    LEUKEMIA, 1995, 9 (03) : 466 - 470
  • [10] Second relapses of childhood acute lymphoblastic leukemia.
    Adams, HP
    MuellerWeihrich, S
    Treuner, J
    Bode, U
    Gutjahr, P
    Beck, JD
    Haas, RJ
    Mertens, R
    Niemeyer, C
    Henze, G
    BLOOD, 1997, 90 (10) : 1488 - 1488
12345